- Written to provide a "hands-on" approach for readers
- Biochemical structures explained with molecular models, and molecular mechanisms explained with simple drawings
- Step-by-step guide to memorize and draw lipid structures
- Each chapter features a content summary, up-to-date references for additional study, and a key experiment with an explanation of the technique
Neuroscience graduate students, post-doctoral fellows, experienced researchers new to neuroscience, and senior researchers that want technique updates
Table of Contents
- About the Authors
- Chapter 1: Chemical Basis of Lipid Biochemistry
- 1.1. Introduction
- 1.2. Chemistry background
- 1.3. Molecular interactions
- 1.4. Solubility in water: what is it?
- 1.5. Lipid biochemistry
- 1.6. Biochemical diversity of brain lipids
- 1.7. A key experiment: lipid analysis by thin layer chromatography
- Chapter 2: Brain Membranes
- 2.1. Why lipids are different from all other biomolecules
- 2.2. Role of structured water in molecular interactions
- 2.3. Lipid self-assembly, a water-driven process?
- 2.4. Lipid–lipid interactions: why such a high specificity?
- 2.5. Nonbilayer phases and lipid dynamics
- 2.6. The plasma membrane of glial cells and neurons: the lipid perspective
- 2.7. Key experiments on lipid density
- Chapter 3: Lipid Metabolism and Oxidation in Neurons and Glial Cells
- 3.1. General aspects of lipid metabolism
- 3.2. Cholesterol
- 3.3. Sphingolipids
- 3.4. Phosphoinositides
- 3.5. Phosphatidic acid
- 3.6. Endocannabinoids
- 3.7. Lipid peroxidation
- 3.8. Key experiment: Alzheimer’s disease, cholesterol, and statins: where is the link?
- Chapter 4: Variations of Brain Lipid Content
- 4.1. Brain lipids: how to bring order to the galaxy
- 4.2. Variations in brain cholesterol content
- 4.3. Variations in brain ganglioside content
- 4.4. Variations in myelin lipids
- 4.5. Impact of nutrition on brain lipid content
- 4.6. Key experiment: the GM1/GM3 balance and Alzheimer’s disease
- Chapter 5: A Molecular View of the Synapse
- 5.1. The synapse: a tripartite entity?
- 5.2. Role of gangliosides in glutamate clearance
- 5.3. Neurotransmitters and their receptors: what physicochemical properties reveal
- 5.4. A dual receptor model for serotonin
- 5.5. A dual receptor model for anandamide
- 5.6. Control of synaptic functions by gangliosides
- 5.7. Control of synaptic functions by cholesterol
- 5.8. Key experiments: debunking myths in neurosciences
- Chapter 6: Protein–Lipid Interactions in the Brain
- 6.1. General aspects of protein–lipid interactions
- 6.2. Annular versus nonannular lipids
- 6.3. Interactions between membrane lipids and cytoplasmic domains
- 6.4. Interactions between membrane lipids and transmembrane domains
- 6.5. Interactions between membrane lipids and extracellular domains
- 6.6. Chaperone effects
- 6.7. Conclusions
- 6.8. Key experiment: the Langmuir monolayer as a universal tool for the study of lipid–protein interactions
- Chapter 7: Lipid Regulation of Receptor Function
- 7.1. Specific lipid requirement of membrane proteins
- 7.2. Nicotinic acetylcholine receptor
- 7.3. Cholesterol- and ganglioside-binding domains in serotonin receptors
- 7.4. Cholesterol- and GalCer-binding domains in sigma-1 receptors
- 7.5. GM1-binding domain in high-affinity NGF receptor
- 7.6. Phosphoinositide binding to purinergic receptors
- 7.7. Key experiment: transfection of membrane receptors: what about lipids?
- Chapter 8: Common Mechanisms in Neurodegenerative Diseases
- 8.1. Amyloidosis: a brief history
- 8.2. Protein structure
- 8.3. Protein folding
- 8.4. Intrinsically disordered proteins (IDPs): the dark side of the proteome
- 8.5. Lipid rafts as platforms for amyloid landing and conversions
- 8.6. Amyloid pores
- 8.7. Amyloid fibrils
- 8.8. Common molecular mechanisms of oligomerization and aggregation
- 8.9. Therapeutic strategies based on lipid rafts
- 8.10. A key experiment: common structure of amyloid oligomers implies common mechanism of pathogenesis
- Chapter 9: Creutzfeldt–Jakob Disease
- 9.1. Prion diseases
- 9.2. PrP: structural features, biological functions, and role in neurological diseases
- 9.3. The mechanism or prion replication: a great intuition and an intellectual journey of an imperturbable logic
- 9.4. Role of lipid rafts in the conformational plasticity of PrP
- 9.5. Conclusion of the investigation: who is guilty, who is innocent?
- 9.6. Key experiment: adenine is a minimal aromatic compound that self-aggregates in water through π–π stacking interactions
- Chapter 10: Parkinson’s Disease
- 10.1. Parkinson’s disease and synucleopathies
- 10.2. α-Synuclein
- 10.3. Intracellular α-synuclein binds to synaptic vesicles and regulates vesicle trafficking, docking, and recycling
- 10.4. α-Synuclein is secreted, extracellular, and taken up by several brain cell types
- 10.5. α-Synuclein: a multifaceted protein with exceptional conformational plasticity
- 10.6. How α-synuclein interacts with membrane lipids
- 10.7. Oligomerization of α-synuclein into Ca2+-permeable annular channels
- 10.8. Electrophysiological studies of oligomeric α-synuclein channels
- 10.9. Cellular targets for α-synuclein in the brain: the lipid connection
- 10.10. Conclusion of the investigation: who is guilty, who is innocent?
- 10.11. Key experiment: pesticides and animal models of Parkinson’s disease
- Chapter 11: Alzheimer’s Disease
- 11.1. Alzheimer’s disease: a rapid survey, from 1906 to 2014
- 11.2. The amyloid paradigm
- 11.3. The calcium hypothesis of Alzheimer’s disease
- 11.4. Amyloid pores: β, α, or both?
- 11.5. Cholesterol
- 11.6. GM1
- 11.7. Lipid rafts: matrix for APP processing and factory for Aβ production
- 11.8. Gender-specific mechanisms
- 11.9. Conclusions of the inquiry
- 11.10. Key experiment: a blood-based test to predict Alzheimer’s disease?
- Chapter 12: Viral and Bacterial Diseases
- 12.1. Overview of brain pathogens
- 12.2. Pathogen traffic to the brain
- 12.3. Overview of brain pathogens
- 12.4. Key experiment: what is a virus receptor?
- Chapter 13: A Unifying Theory
- 13.1. Why do we need a unifying theory?
- 13.2. Bacteria, viruses, and amyloids converge at brain membranes
- 13.3. Glycosphingolipids and cholesterol in brain membranes: “un pas de deux”
- 13.4. Geometric aspects of glycolipid–protein and cholesterol interactions
- 13.5. Why two lipid receptors are better than one?
- 13.6. When cholesterol plays two roles
- 13.7. Structural disorder as a common trait of pathogenicity
- 13.8. Key experiment: probes to study cholesterol and/or glycolipid-dependent mechanisms
- Chapter 14: Therapeutic Strategies for Neurodegenerative Diseases
- 14.1. Proteins involved in brain diseases considered as infectious proteins
- 14.2. How to prevent the interaction of pathogenic proteins with brain membranes
- 14.3. How to prevent the insertion of pathogenic proteins into brain membranes
- 14.4. How to block amyloid pore formation
- 14.5. A universal ganglioside-binding peptide
- 14.6. A universal squatter of cholesterol-binding sites
- 14.7. Could anti-HIV drugs also be considered for the treatment of neurodegenerative diseases?
- 14.8. Conclusions
- 14.9. A key experiment: PAMPA-BBB, a lipid-based model for the blood–brain barrier
- Subject Index
- No. of pages: 398
- Language: English
- Copyright: © Academic Press 2015
- Published: May 12, 2015
- Imprint: Academic Press
- Hardcover ISBN: 9780128001110
- eBook ISBN: 9780128004920
About the Authors
Affiliations and Expertise
Affiliations and Expertise
Ratings and Reviews
(Total rating for all reviews)
Margaux Sat Aug 21 2021
Livre excellent. Très bien documenté et complet.
Le meilleur livre sur le sujet. Impressionnant. On y apprend tout ce qu'il faut connaître sur le sujet et même plus! Très utile.
sabatier Sat Aug 21 2021
Oustanding book. Highly recommend.
Excellent livre! A ne pas manquer.
Tristan Sat Aug 21 2021
Best book in the field
Excellent. Best book in field.